Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioequivalence and intrasubject variability.

J P Liu1

  • 1Berlex Laboratories, Inc., Wayne, New Jersey 07470.

Journal of Biopharmaceutical Statistics
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrine inhibits the proliferation, migration, invasion, and stemness of thymoma cells by regulating the Wnt3a/Β-catenin pathway.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same author

[Type 2 autoimmune pancreatitis: a clinicopathological analysis].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2025
Same author

[Herpetic esophagitis: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2025
Same author

[Diagnostic and intervention value of implantable cardiac monitor in patients over 60 years of age with unexplained syncope].

Zhonghua xin xue guan bing za zhi·2024
Same author

[Multicenter evaluation of the diagnostic efficacy of jaundice color card for neonatal hyperbilirubinemia].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2024
Same author

[Clinical features and lymphocyte subtypes in patients with IgG<sub>4</sub>-related diseases].

Zhonghua nei ke za zhi·2024
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces a method to assess intrasubject variability equivalence in bioavailability for bioequivalence studies. The confidence interval approach is shown to be equivalent to hypothesis testing for this assessment.

Area of Science:

  • Pharmacokinetics and Pharmaceutical Sciences
  • Biostatistics
  • Drug Development

Background:

  • Bioequivalence ensures drug formulations have comparable bioavailability.
  • Equivalence requires matching average and intrasubject variability.
  • Standard bioequivalence studies often use a two-by-two crossover design.

Purpose of the Study:

  • To introduce a procedure for assessing intrasubject variability equivalence in bioavailability.
  • To evaluate the equivalence of intrasubject variability in bioequivalence studies.
  • To demonstrate the application of the procedure using a hypothetical dataset.

Main Methods:

  • Development of a statistical procedure for intrasubject variability equivalence.
  • Utilizing the standard two-by-two crossover design for bioequivalence studies.

Related Experiment Videos

  • Comparison of confidence interval approach with hypothesis testing for variability assessment.
  • Main Results:

    • The proposed procedure effectively assesses intrasubject variability equivalence.
    • Confidence interval approach and hypothesis testing yield identical operational outcomes for variability assessment.
    • A hypothetical dataset illustrates the practical application of the method.

    Conclusions:

    • A reliable method for evaluating intrasubject variability equivalence in bioequivalence studies is presented.
    • The confidence interval method offers a practical alternative for assessing variability equivalence.
    • The findings contribute to robust bioequivalence study designs.